Reply to Comment on: Multifocal vitelliform paravascular retinopathy (MVPR): A new disorder in the vitelliform spectrum

Jul 26, 2025 by in OPHTHALMOLOGY Comments Off on Reply to Comment on: Multifocal vitelliform paravascular retinopathy (MVPR): A new disorder in the vitelliform spectrum

B oon and associates provide important and insightful comments regarding the multifocal vitelliform paravascular retinopathy (MVPR) phenotype. We agree that it is important to consider exposure to mitogen-activated protein kinase…

read more

Comment on: Multifocal Vitelliform Paravascular Retinopathy (MVPR): A New Disorder in the Vitelliform Spectrum

Jul 26, 2025 by in OPHTHALMOLOGY Comments Off on Comment on: Multifocal Vitelliform Paravascular Retinopathy (MVPR): A New Disorder in the Vitelliform Spectrum

Song and co-workers report a striking clinical picture, which they named “multifocal vitelliform paravascular retinopathy” (MVPR), and state that this is a unique and novel disorder within the vitelliform spectrum….

read more

Adherence and Persistence on Prostaglandin Analogues for Glaucoma: A Systematic Review and Meta-Analysis

Jul 26, 2025 by in OPHTHALMOLOGY Comments Off on Adherence and Persistence on Prostaglandin Analogues for Glaucoma: A Systematic Review and Meta-Analysis

PURPOSE To systematically review, synthesize and quantify studies reporting patterns of adherence and persistence with prostaglandin analogues (PGAs) in order to comprehensively understand real-world treatment behavior among patients with glaucoma…

read more

Retinal Vascularization Rate Predicts Retinopathy of Prematurity and Remains Unaffected by Low-Dose Bevacizumab Treatment

Jul 26, 2025 by in OPHTHALMOLOGY Comments Off on Retinal Vascularization Rate Predicts Retinopathy of Prematurity and Remains Unaffected by Low-Dose Bevacizumab Treatment

Highlights • Ultra-widefield imaging enables monitoring of retinal vascularization rate. • Slow retinal vascularization is an early predictor of treatment-requiring retinopathy of prematurity. • Low-dose bevacizumab does not slow physiological…

read more

Gender Differences in Patient-Physician Communication in Ophthalmic Practice, Pre- and Post-COVID-19 Period

Jul 26, 2025 by in OPHTHALMOLOGY Comments Off on Gender Differences in Patient-Physician Communication in Ophthalmic Practice, Pre- and Post-COVID-19 Period

Highlights • Gender differences exist in ophthalmologist communication patterns. • Female ophthalmologists seem to use a more patient-centered communication style. • The COVID-19 pandemic impacted ophthalmologist communication patterns. • Burnout…

read more
Get Clinical Tree app for offline access